A neurologist by training, Dr. Saltarelli heads up the Early Development and Neurology Group, an area that addresses the early clinical stage of the drug development cycle, as well as development of all of our potential neurological medicines.
As soon as you walk in the door, you feel why Vertex is a special place. We have not only the resources, but also a strategy to tackle high unmet medical needs and to develop novel therapeutics that address them. Everything we do is dedicated toward patients and bringing them new medicines as quickly as possible.
“You can think of early development as the experimental phase. We’re not in the lab with test tubes, but we conduct experiments and test hypotheses as if we were scientists in a lab. Having strong pre-clinical models allows us – at a very early stage – to predict how the medicine will perform in a patient. It’s much less of a shot in the dark.”